Skip to main content
. 2005 Mar 19;330(7492):662–665. doi: 10.1136/bmj.330.7492.662

Table 2.

Difference (end of trial minus baseline) in SF-36 scores that were significantly different between intervention and control groups, by project. Values are means (SD)

Project Intervention group Control group
Central region
Cardiac: (n=99) (n=57)
Role physical component summary 2.30 (9.45) −1.91 (8.35)
Role limitation from physical problems 10.6 (44.48) −6.58 (41.33)
Bodily pain 2.19 (21.29) −7.51 (26.89)
General health 2.90 (15.47) −1.49 (19.41)
Vitality 4.44 (17.79) −3.33 (19.05)
Eyre Peninsula region
Chronic and complex: (n=443) (n=195)
Role physical component summary 1.05 (9.87) −1.09 (10.2)
Limitation of physical activities 1.76 (19.69) −2.41 (20.53)
Social limitations 2.15 (28.41) −3.59 (27.69)
Southern region
Respiratory: (n=85) (n=47)
Vitality 2.94 (20.45) −2.34 (16.18)
Care of elderly people: (n=299) (n=150)
Role physical component summary 0.50 (10.82) −2.06 (10.43)
Role limitation from physical problems 3.76 (46.75) −6.83 (44.31)
Social limitations −1.17 (30.03) −9.00 (27.29)
Western region
Respiratory: (n=83) (n=67)
Role mental component summary 2.93 (15.13) −3.75 (13.76)
Social limitations 2.71 (34.71) −11.0 (31.87)
Mental health 5.93 (17.87) −4.48 (16.41)
Diabetes: (n=132) (n=97)
Role physical component summary 0.53 (10.19) −2.52 (9.71)
Limitation of physical activities −2.73 (21.27) −8.11 (19.13)
Bodily pain 3.12 (26.10) −3.31 (21.87)
Social limitations −3.23 (30.68) −9.79 (22.55)

Higher score=improved health status.